What's Happening?
Northwell Health’s Feinstein Institutes for Medical Research has received an $8.9 million multi-year grant from the National Institutes of Health’s (NIH) National Institute on Aging (NIA). This funding is part of a larger NIA grant exceeding $40 million.
The grant will support the Advancing Ethical Goals in Society (AEGIS) clinical trial, a collaborative effort with Tufts University and Dartmouth Health. The AEGIS trial aims to transform advanced care planning for older adults and individuals with Alzheimer’s disease and related dementias (AD/ADRD). Dr. Edith Burns, a professor at the Institute of Health System Science at the Feinstein Institutes, will lead the trial. Co-investigators include Dr. Santiago Lopez, interim chief of Geriatrics and Palliative Medicine for Northwell Health’s central market, and Dr. Philip Solomon, director of Faculty Development and Education, Northwell Institute for Healthy Aging. The program will develop video education tools and deploy trained Advanced Care Planning (ACP) educators to empower patients and their families in making informed medical decisions.
Why It's Important?
This grant is crucial for ensuring that older adults and patients with dementia receive medical care that aligns with their personal values and wishes. The AEGIS trial's approach, utilizing engaging video education and dedicated educators, is designed to facilitate critical conversations within families, leading to more informed decision-making and greater peace of mind. For the AD/ADRD community, where cognitive decline can complicate expressing preferences, this initiative is particularly vital. By providing clear, accessible information and dedicated support, the program aims to uphold patient preferences, which can significantly improve quality of life, reduce healthcare burdens, and promote dignified, compassionate care. This funding underscores Northwell Health’s commitment to innovation in healthcare, extending beyond traditional lab research and acute hospital settings into long-term and home care.
What's Next?
The AEGIS clinical trial will commence with the development of video education tools and the training of a dedicated force of Advanced Care Planning (ACP) educators. These educators will then work directly with older patients and individuals with Alzheimer’s disease and related dementias, along with their families, to guide them through complex medical decisions. The trial's progress will be monitored by the Feinstein Institutes, Tufts University, and Dartmouth Health, with the goal of assessing the effectiveness of this new approach in empowering patients and ensuring their care preferences are honored. Successful outcomes from the AEGIS trial could lead to broader implementation of these advanced care planning strategies across other healthcare systems and potentially influence national guidelines for dementia care.
Beyond the Headlines
The AEGIS trial addresses a significant ethical challenge in healthcare: ensuring patient autonomy and dignity, especially for vulnerable populations like older adults and those with dementia. The use of video education and trained educators represents an innovative approach to bridging communication gaps and empowering individuals who might otherwise struggle to articulate their wishes. This initiative could set a new standard for patient-centered care, emphasizing proactive planning rather than reactive decision-making during crises. Furthermore, by alleviating healthcare burdens through better-informed choices, the program has the potential to impact healthcare resource allocation and reduce the emotional and financial strain on families. The collaboration between major research institutions also highlights a growing recognition of the need for interdisciplinary approaches to complex health and ethical issues.
